Farmacovigilanza

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial

focus /

I farmaci antipertensivi in gravidanza

Questo è il secondo di una serie di articoli pubblicati da Focus Farmacovigilanza sulla prescrizione dei farmaci in gravidanza, il primo è consultabile qui: https://www.farmacovigilanza.eu/content/la-prescrizione-dei-farmaci-grav...

Lingua Italiano

Switching From Reference to Biosimilar Insulin Aspart for Patients With Diabetes Mellitus (Type 1 or Type 2)

Wed, 17 Nov 2021 09:54:11 -0500

Lingua Italiano

Leadless Pacing Systems: Risk of Major Complications Related to Cardiac Perforation During Implantation - Letter to Health Care Providers

The FDA is reminding providers about the risk of major complications if cardiac perforation occurs during implant of leadless pacemakers

Lingua Italiano

Odor-Eaters® Issues Voluntary Nationwide Recall of Specific Lots of Odor- Eaters® Spray Powder and Odor-Eaters® Stink Stoppers® Spray Due to Benzene Contamination

Odor-Eaters®, owned by Blistex Inc., is voluntarily recalling a total of forty-one lots of two Odor-Eaters® spray products to the consumer level due to the presence of benzene. Internal testing identified low levels of benzene contamination in specific lots of these aerosol products.

Lingua Italiano